Cited 0 times in Scipus Cited Count

Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer.

DC Field Value Language
dc.contributor.authorPark, JH-
dc.contributor.authorBae, SH-
dc.contributor.authorJung, YS-
dc.contributor.authorJung, YM-
dc.date.accessioned2017-01-12T04:20:24Z-
dc.date.available2017-01-12T04:20:24Z-
dc.date.issued2015-
dc.identifier.issn2005-3673-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/13411-
dc.description.abstractPURPOSE: Evidence suggests that some patients with breast cancer experience cognitive difficulties following chemotherapy. This longitudinal study was done to examine the prevalence of cognitive impairment and trajectory of cognitive function over time in women with breast cancer, who received adjuvant chemotherapy.
METHODS: Participants were 137 patients with breast cancer. They completed neuropsychological tests and the Functional Assessment of Cancer Therapy-Cognitive Function before adjuvant therapy (pretest), toward the end of adjuvant therapy (posttest), and 6 months after the completion of adjuvant therapy (follow-up test). Of the patients, 91 were treated with adjuvant chemotherapy and 46 patients who did not receive chemotherapy made up the comparison group. A reliable-change index and repeated-measure ANOVA were used for statistical analyses.
RESULTS: At the posttest point, over 30% of patients showed complex cognitive impairment and reported greater difficulty in subjective cognitive function. At the follow-up test point, 22.0% of patients exhibited complex cognitive impairment and 30.8% of patients complained of subjective cognitive impairment. Repeated-measure ANOVA showed significant decreases after receiving chemotherapy followed by small improvements 6 months after the completion of chemotherapy in cognitive domains of change for attention and concentration, memory, executive function, and subjective cognitive function.
CONCLUSION: These results suggest that chemotherapy in patients with breast cancer may be associated with objective and subjective cognitive impairments. Further studies are needed to explore the potential risk factors and predictor of chemotherapy-related cognitive changes. Also nursing interventions for prevention and intervention of cognitive impairments should be developed and tested.
en
dc.formatapplication/pdf-
dc.language.isoko-
dc.subject.MESHAdult-
dc.subject.MESHAnalysis of Variance-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols-
dc.subject.MESHAttention-
dc.subject.MESHBreast Neoplasms-
dc.subject.MESHChemotherapy, Adjuvant-
dc.subject.MESHCognitive Dysfunction-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHLongitudinal Studies-
dc.subject.MESHMemory-
dc.subject.MESHMiddle Aged-
dc.titlePrevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer.-
dc.title.alternative유방암 환자에서 화학요법관련 인지기능저하의 발생률과 발생양상-
dc.typeArticle-
dc.identifier.pmid25743740-
dc.subject.keywordBreast neoplasms-
dc.subject.keywordAdjuvant chemotherapy-
dc.subject.keywordAttention-
dc.subject.keywordMemory-
dc.subject.keywordExecutive function-
dc.contributor.affiliatedAuthor박, 진희-
dc.contributor.affiliatedAuthor정, 용식-
dc.type.localJournal Papers-
dc.identifier.doi10.4040/jkan.2015.45.1.118-
dc.citation.titleJournal of Korean Academy of Nursing-
dc.citation.volume45-
dc.citation.number1-
dc.citation.date2015-
dc.citation.startPage118-
dc.citation.endPage128-
dc.identifier.bibliographicCitationJournal of Korean Academy of Nursing, 45(1). : 118-128, 2015-
dc.identifier.eissn2093-758X-
dc.relation.journalidJ020053673-
Appears in Collections:
Journal Papers > College of Nursing Science / Graduate School of Nursing Sciences > Nursing Science
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Files in This Item:
25743740.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse